| CDPS | calcium-dependent protease small subunit |
|---|---|
| CTRL | chymotrypsin-like [protease] |
| HFSP | Hanukah factor serine protease |
| KPI | kallikrein-protease inhibitor; karyopyknotic index |
| LMP | large multifunctional protease; last menstrual period; latent membrane potential; left mentoposterio... |
| neurotransmitter uptake inhibitors | Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects. (12 Dec 1998) |
|---|---|
| nucleic acid synthesis inhibitors | Compounds that inhibit cell production of DNA or RNA. (12 Dec 1998) |
| dopamine uptake inhibitors | Drugs that block the transport of dopamine into axon terminals or into storage vesicles within terminals. most of the adrenergic uptake inhibitors also inhibit dopamine uptake. (12 Dec 1998) |
| integrase inhibitors | Compounds which inhibit or antagonise biosynthesis or actions of integrase. (12 Dec 1998) |
| tissue inhibitors of metalloproteinase | <cell biology> Family of proteins of around 200 residues that can inhibit metalloproteinases, for example collagenase, by binding to them. (18 Nov 1997) |
| enzyme inhibitors | Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (12 Dec 1998) |
| enzymes, coenzymes, and enzyme inhibitors | Proteins or RNA that act as biological catalysts, their cofactors, and inhibitors. (12 Dec 1998) |
| trypsin inhibitors | Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (12 Dec 1998) |
| lipoxygenase inhibitors | Compounds or agents that combine with lipoxygenase and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of the eicosanoid products hydroxyeicosatetraenoic acid and various leukotrienes. (12 Dec 1998) |
| AB-C protease | <enzyme> From agkistrodon bilineatus; activates protein c; inhibited by calcium; amino acid sequence given in first source Registry number: EC 3.4.21.- (26 Jun 1999) |
| acid protease | <enzyme> Any of many protein-hydrolysing rennin. Similar proteases produced by fungi such as Aspergillus oryzae are used in the manufacture of flour and soy sauce. (06 May 1997) |
| AH-101 thermostable alkaline protease | <enzyme> Isolated from bacillus sp. No. Ah-101; has sequence similarity to other subtilisin-like enzymes Registry number: EC 3.4.21.- Synonym: ah-101 protease (26 Jun 1999) |
| alkaline protease | <enzyme> These proteases work best in the pH range of 8 to 11 and are used widelyin washing powders and to de-hair hides. Alkaline proteases are mainlyproduced by bacteria in the Bacillus species. (13 Nov 1997) |
| Alp protease | <enzyme> Gene alpa (previously called alp) does not encode its components, although is involved with its activity Registry number: EC 3.4.99.- (26 Jun 1999) |
| amyloid A-degrading serine protease | <enzyme> Reduced in amyloidosis associated with rheumatoid arthritis Registry number: EC 3.4.21.- Synonym: amyloid a-degrading activity, aad-protease (26 Jun 1999) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|